Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 1
1982 1
1983 2
1984 3
1985 2
1988 4
1989 6
1990 3
1991 1
1992 4
1993 3
1994 4
1995 5
1996 6
1997 8
1998 5
1999 1
2000 2
2001 2
2002 3
2004 1
2009 2
2010 2
2011 8
2012 1
2014 1
2015 2
2016 2
2017 5
2018 3
2019 2
2020 1
2021 1
2022 1
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study.
Casulo C, Byrtek M, Dawson KL, Zhou X, Farber CM, Flowers CR, Hainsworth JD, Maurer MJ, Cerhan JR, Link BK, Zelenetz AD, Friedberg JW. Casulo C, et al. Among authors: farber cm. J Clin Oncol. 2015 Aug 10;33(23):2516-22. doi: 10.1200/JCO.2014.59.7534. Epub 2015 Jun 29. J Clin Oncol. 2015. PMID: 26124482 Free PMC article.
Sulfadiazine revisited.
Ventura MG, Wybran J, Farber CM. Ventura MG, et al. Among authors: farber cm. J Infect Dis. 1989 Sep;160(3):556-7. doi: 10.1093/infdis/160.3.556. J Infect Dis. 1989. PMID: 2760508 No abstract available.
Substitution therapy for C1 esterase deficiency.
Farber CM, Gourdin A, Lambermont M, Gilbert C, Van Vooren JP. Farber CM, et al. Lancet. 1992 Jan 11;339(8785):119. doi: 10.1016/0140-6736(92)91023-2. Lancet. 1992. PMID: 1345835 No abstract available.
Treatment of Peripheral T-Cell Lymphoma in Community Settings.
Feldman T, Farber CM, Choi K, Faria C, Goy A, Connors J, Paramanathan D, Kaur S, Schultz E, McGuire M, Goldberg SL. Feldman T, et al. Among authors: farber cm. Clin Lymphoma Myeloma Leuk. 2017 Jun;17(6):354-361. doi: 10.1016/j.clml.2017.05.001. Epub 2017 May 10. Clin Lymphoma Myeloma Leuk. 2017. PMID: 28622960
Zanubrutinib in patients with treatment-naïve or relapsed/refractory Waldenström macroglobulinemia: An expanded-access study of 50 patients in the United States.
Castillo JJ, Kingsley EC, Narang M, Yimer HA, Dasanu CA, Melear JM, Coleman M, Farber CM, Shulman J, Mantovani EH, Zhang X, Cohen A, Huang J. Castillo JJ, et al. Among authors: farber cm. EJHaem. 2023 Jan 11;4(1):301-304. doi: 10.1002/jha2.619. eCollection 2023 Feb. EJHaem. 2023. PMID: 36819162 Free PMC article. No abstract available.
Mevalonate kinase deficiency: a survey of 50 patients.
Bader-Meunier B, Florkin B, Sibilia J, Acquaviva C, Hachulla E, Grateau G, Richer O, Farber CM, Fischbach M, Hentgen V, Jego P, Laroche C, Neven B, Lequerré T, Mathian A, Pellier I, Touitou I, Rabier D, Prieur AM, Cuisset L, Quartier P; SOFREMIP (Société Francophone pour la Rhumatologie et les Maladies Inflammatoires en Pédiatrie); CRI (Club Rhumatismes et Inflammations). Bader-Meunier B, et al. Among authors: farber cm. Pediatrics. 2011 Jul;128(1):e152-9. doi: 10.1542/peds.2010-3639. Epub 2011 Jun 27. Pediatrics. 2011. PMID: 21708801
[Immune deficiencies: diagnosis, management, some perspectives].
Farber CM, Benoit Y, Boven K, De Baets F, Ferster A, Hoyoux C, Mascart F, Otten J, Philippet P, Van Lierde S, Van Vooren JP, Vermylen C. Farber CM, et al. Rev Med Brux. 2001 Apr;22(2):73-82. Rev Med Brux. 2001. PMID: 11388026 Review. French.
96 results